Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 150,894 $ 194,263
Short-term deposits 55,031 54,620
Accounts receivable, net of allowance for doubtful accounts of $- and $- (including amounts due from related parties of $- and $2)   744
Other current assets and prepaid expenses (including current portion of clinical materials) 12,257 13,420
Total current assets 218,182 263,047
Restricted cash 4,229 4,508
Clinical materials 2,695 4,736
Property, plant and equipment, net 13,444 13,225
Intangibles, net 1,010 305
Total assets 239,560 285,821
Current liabilities    
Accounts payable (including amounts due to related parties of $9 and $-) 2,474 7,884
Accrued expenses and other accrued liabilities (including amounts due to related parties of $77 and $288) 7,723 7,518
Deferred revenue 9,940 12,487
Total current liabilities 20,137 27,889
Deferred revenue, less current portion 22,432 22,939
Total liabilities 42,569 50,828
Contingencies and commitments - Note 8
Equity    
Common stock - Ordinary shares par value GBP 0.001, 574,711,900 authorized and 424,711,900 issued and outstanding (2015: 574,711,900 authorized and 424,711,900 issued and outstanding) 682 682
Additional paid in capital 336,904 332,363
Accumulated other comprehensive loss (13,011) (8,139)
Accumulated deficit (127,584) (89,913)
Total equity 196,991 234,993
Total liabilities and stockholders' equity $ 239,560 $ 285,821